2024 Exhibitors Search
NEORTESBIO Inc.
| Country | Korea, South |
|---|---|
| Address | |
| Tel (Rep.) | 070-4570-7847 |
| Website | http://www.neortesbio.com |
Company Introduction
NEORTESBIO, a leading South Korean biotech firm, specializes in developing therapeutic antibodies for retinal diseases, solid tumors, and age-related conditions, with a primary focus on the Angiopoietin-Tie axis a crucial pathway in vasculature regulation.
Our proprietary Tri-VasTrap™, an Ang2-binding and Tie2-activating antibody (ABTAA), stands out by effectively regenerating and normalizing pathologic capillaries, distinguishing itself from conventional VEGF-inhibitors that disrupt vessels.
Our proprietary Tri-VasTrap™, an Ang2-binding and Tie2-activating antibody (ABTAA), stands out by effectively regenerating and normalizing pathologic capillaries, distinguishing itself from conventional VEGF-inhibitors that disrupt vessels.
Promotional video
Exhibit Item
Antibody Therapeutics for the Treatment of wAMD and DR
Exhibit Item Images
-
Product Name : Tri-VasTrapNEORTESBIO’s Tri-VasTrap™ shows promise in retinal disease treatment, especially DR and ROP. In mouse models, it outperformed Aflibercept and Faricimab in restoring retinal vessels and avascular areas. Additionally, it aids retinal cell recovery and choriocapillaris regeneration in AMD, offering hope for patients unresponsive to VEGF inhibitors.
Exhibit Description
Co-Exhibitor or Partner’s Information
| Company Name | Country |
|---|---|
KYUNGYON EXHIBITION CORP.